Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2013
89Zr-bevacizumab PET imaging in primary breast cancerSietske B M Gaykema, Adrienne H Brouwers, Marjolijn N Lub-de Hooge, et al.Breast Cancer Research : BCR|September 25, 2010
Receptor conversion in distant breast cancer metastasesLaurien D C Hoefnagel, Marc J van de Vijver, Henk-Jan van Slooten, et al.International Journal of Cancer|August 22, 2024
B cells critical for outcome in high grade serous ovarian carcinomaAnnegé Vledder, Sterre T Paijens, Dominik Loiero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II TrialAnneke L Eerkens, Martha D Esajas, Koen Brummel, et al.Familial Cancer|May 5, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical dataLieke Lanjouw, Claire J H Kramer, Arja Ter Elst, et al.Nature Communications|September 3, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I studyAnneke L Eerkens, Koen Brummel, Annegé Vledder, et al.Journal of the National Cancer Institute|November 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.Histopathology|August 5, 2025
Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia (dVIN): an international reproducibility studyShatavisha Dasgupta, Anne-Sophie Van Rompuy, Christine Bergeron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical FactorsIris A S Stroot, Jan Brouwer, Joost Bart, et al.Biopreservation and Biobanking|April 29, 2024
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other BiobanksHein S Zelisse, Sander de Ridder, Mignon D J M van Gent, et al.Pageof 7